Immunohistochemistry of mammary Paget’s disease

References

1. ↵
   1. Adams SJ,
   2. Kanthan R

   (2016) Paget's disease of the male breast in the 21st century:A systematic review. Breast 29:14–23.

   OpenUrl
2. ↵
   1. Song Q,
   2. Jin Y,
   3. Huang T,
   4. Zhang JH

   (2015) Diagnosis and treatment of Paget's disease of the breast:an analysis of 72 cases. Int J Clin Exp Med 8:19616–19620.

   OpenUrl
3. ↵
   1. Karakas C

   (2011) Paget's disease of the breast. J Carcinog 10:31.

   OpenUrlPubMed
4. ↵
   1. Muttarak M,
   2. Siriya B,
   3. Kongmebhol P,
   4. Chaiwun B,
   5. Sukhamwang N

   (2011) Paget's disease of the breast:clinical, imaging and pathologic findings:a review of 16 patients. Biomed Imaging Interv J 7:e16.

   OpenUrlPubMed
5. ↵
   1. Günhan-Bilgen I,
   2. Oktay A

   (2006) Paget's disease of the breast:clinical, mammographic, sonographic and pathologic findings in 52 cases. Eur J Radiol 60:256–263.

   OpenUrlCrossRefPubMed
6. ↵
   1. Zhou H,
   2. Lu K,
   3. Zheng L,
   4. Guo L,
   5. Gao Y,
   6. Miao X,
   7. et al.

   (2018) Prognostic significance of mammary Paget's disease in Chinese women:a 10-year, population-based, matched cohort study. Onco Targets Ther 11:8319–8326.

   OpenUrl
7. ↵
   1. Moatamed NA,
   2. Wu A,
   3. Sarah K,
   4. Apple SK

   (2015) Cytokeratin 7 negative invasive breast carcinoma:clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up. J Clin Pathol 68:484–487.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Ozerdem U,
   2. McNiff JM,
   3. Tavassoli FA

   (2016) Cytokeratin 7-negative mammary Paget's disease:A diagnostic pitfall. Pathol Res Pract 212:279–281.

   OpenUrl
9. ↵
   1. Asch-Kendrick R,
   2. Cimino-Mathews A

   (2016) The role of GATA3 in breast carcinomas:a review. Hum Pathol 48:37–47.

   OpenUrl
10. ↵
    1. Mai R,
    2. Zhou S,
    3. Zhou S,
    4. Zhong W,
    5. Hong L,
    6. Wang Y,
    7. et al.

    (2018) Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease. Hum Pathol 77:152–158.

    OpenUrl
11. ↵
    1. Wachter DL,
    2. Wachter PW,
    3. Fasching PA,
    4. Beckmann MW,
    5. Hack CC,
    6. Riener MO,
    7. et al.

    (2019) Characterization of molecular subtypes of paget disease of the breast using immunohistochemistry and in situ hybridization. Arch Pathol Lab Med 143:206–211.

    OpenUrl
12. ↵
    1. Miettinen M,
    2. McCue PA,
    3. Sarlomo-Rikala M,
    4. Rys J,
    5. Czapiewski P,
    6. Wazny K,
    7. et al.

    (2014) GATA3:a multispecific but potentially useful marker in surgical pathology:a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13–22.

    OpenUrlCrossRefPubMed
13. ↵
    1. Wolff AC,
    2. Hammond MEH,
    3. Allison KH,
    4. Harvey BE,
    5. Mangu PB,
    6. Bartlett JMS,
    7. et al.

    (2018) Human epidermal growth factor receptor 2 testing in breast cancer:American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36:2105–2122.

    OpenUrlCrossRefPubMed
14. ↵
    1. Liegl B,
    2. Horn LC,
    3. Moinfar F

    (2005) Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol 18:1283–1288.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Arafah M,
    2. Arain SA,
    3. Raddaoui EMS,
    4. Tulba A,
    5. Alkhawaja FH,
    6. Al Shedoukhy A

    (2019) Molecular subtyping of mammary Paget's disease using immunohistochemistry. Saudi Med J 40:440–446.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. Alnegheimish NA,
    2. Alshatwi RA,
    3. Alhefdhi RM,
    4. Arafah MM,
    5. AlRikabi AC,
    6. Husain S

    (2016) Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study. Saudi Med J 37:506–512.

    OpenUrlAbstract/FREE Full Text